Renalytix Ai Stock Price To Sales
Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.
Renalytix |
Renalytix AI Company Price To Sales Analysis
Renalytix's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Renalytix Price To Sales | 9.85 X |
Most of Renalytix's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Renalytix AI has a Price To Sales of 9.8506 times. This is 53.97% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 13.74% higher than that of the company.
Renalytix Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Renalytix could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics of similar companies.Renalytix is currently under evaluation in price to sales category among its peers.
Renalytix Fundamentals
| Return On Equity | -10.73 | |||
| Return On Asset | -0.94 | |||
| Operating Margin | (9.43) % | |||
| Current Valuation | 36.84 M | |||
| Shares Outstanding | 82.96 M | |||
| Shares Owned By Insiders | 4.51 % | |||
| Shares Owned By Institutions | 4.13 % | |||
| Number Of Shares Shorted | 378.92 K | |||
| Price To Book | 18.77 X | |||
| Price To Sales | 9.85 X | |||
| Revenue | 2.29 M | |||
| Gross Profit | 720 K | |||
| EBITDA | (28.52 M) | |||
| Net Income | (33.46 M) | |||
| Cash And Equivalents | 32.36 M | |||
| Cash Per Share | 0.89 X | |||
| Total Debt | 8.54 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.48 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (30.11 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.62) X | |||
| Target Price | 2.5 | |||
| Beta | 2.1 | |||
| Market Capitalization | 22.55 M | |||
| Total Asset | 7.97 M | |||
| Retained Earnings | (211.78 M) | |||
| Working Capital | 12.2 M | |||
| Net Asset | 7.97 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Renalytix Stock
If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |